132 related articles for article (PubMed ID: 4809461)
1. The detection of alpha 1-fetoprotein in patients with viral hepatitis.
Silver HK; Deneault J; Gold P; Thompson WG; Shuster J; Freedman SO
Cancer Res; 1974 Jan; 34(1):244-7. PubMed ID: 4809461
[TBL] [Abstract][Full Text] [Related]
2. [Significance of serum alpha-fetoprotein determination. Experiences with our own radioimmunoassay].
Lamerz R; Schmalhorst U; Grunst J; Fateh-Moghadam A; Eisenburg J
Fortschr Med; 1976 Apr; 94(12):702-10. PubMed ID: 61154
[TBL] [Abstract][Full Text] [Related]
3. Relationship of serum alpha-fetoprotein to the severity and duration of illness in patients with viral hepatitis.
Bloomer JR; Waldmann TA; McIntire R; Klatskin G
Gastroenterology; 1975 Feb; 68(2):342-50. PubMed ID: 163780
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus antigen quantitation by radioimmunoassay (RIA) in viral hepatitis and in chronic liver diseases.
De Ritis F; Gravina E; Squame G
Acta Hepatogastroenterol (Stuttg); 1975 Feb; 22(1):4-13. PubMed ID: 804225
[TBL] [Abstract][Full Text] [Related]
5. Alpha1-fetoprotein and liver-specific antigen in viral hepatitis type B.
Smith JB; Barker LF
Arch Intern Med; 1974 Mar; 133(3):437-9. PubMed ID: 4204406
[No Abstract] [Full Text] [Related]
6. Hepatitis B antigen, alpha1 fetoprotein and liver disease in the eastern highlands of Papua New Guinea.
Clarke CW; Woodfield G
Trop Geogr Med; 1975 Mar; 27(1):52-8. PubMed ID: 49112
[TBL] [Abstract][Full Text] [Related]
7. Serum alpha-fetoprotein levels in acute viral hepatitis.
Kew MC; Purves LR; Bersohn I
Gut; 1973 Dec; 14(12):939-42. PubMed ID: 4131854
[TBL] [Abstract][Full Text] [Related]
8. [Radioimmunologic determination of alpha fetoprotein in diagnosis of primary tumors of the liver].
Banfi F
Quad Sclavo Diagn; 1975 Jun; 11(2):415-8. PubMed ID: 57625
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Alpha 1-fetoprotein: need for quantitative assays.
Alpert E
N Engl J Med; 1974 Mar; 290(10):568-9. PubMed ID: 4129924
[TBL] [Abstract][Full Text] [Related]
10. [Serum alpha-fetoprotein (AFP) levels in liver cirrhosis and viral hepatitis cases].
Imir T
Mikrobiyol Bul; 1981 Jan; 15(1):7-13. PubMed ID: 6188026
[TBL] [Abstract][Full Text] [Related]
11. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
[TBL] [Abstract][Full Text] [Related]
12. Immunological studies in children with acute viral hepatitis.
Kanakoudi F; Nikolaidis A; Daniilidis B; Manios S; Zurukzoglu SS; Cassimos C
Clin Exp Immunol; 1975 Oct; 22(1):78-83. PubMed ID: 1212817
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
Peng YC; Chan CS; Chen GH
Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
[TBL] [Abstract][Full Text] [Related]
15. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3.
Okuda H; Saito A; Shiratori K; Yamamoto M; Takasaki K; Nakano M
J Gastroenterol Hepatol; 2005 May; 20(5):759-64. PubMed ID: 15853991
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
[TBL] [Abstract][Full Text] [Related]
18. Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease.
Husby G; Strickland RG; Caldwell JL; Williams RC
J Clin Invest; 1975 Nov; 56(5):1198-1209. PubMed ID: 52655
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
Harada T; Shigeta K; Noda K; Fukumoto Y; Nishimura H; Mizuta M; Takemoto T
Hepatogastroenterology; 1980 Jun; 27(3):169-75. PubMed ID: 6161869
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
